Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
Pilot Randomized Trial of a Virtual, Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer: Exploring Dose of Support to Optimize Adherence
- Metastatic Breast Cancer
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- M.D. Anderson Cancer Center
- Enrolment target
- 100
- Started
- 21 August 2026
- Main results due
- 1 October 2027
- Study sites
- 1
- Registry updated
- 25 September 2026
Can you take part?
- Aged 18 years and over.
- Women only.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Patients with HR+/HER2 negative MBC 2. On first- or second-line treatment 3. Life expectancy at least 12 months 4. Only females 5. Age 18 years or older 6. Able to read, write, and speak English 7. Willingness to follow protocol requirements 8. Have a smartphone with access to cellular service or computer access with internet service 9. Oriented to person, place, and time 10. Consume less than 3 servings of fruit and vegetable/day 11. Engage in less than 150 minutes moderate/vigorous intensity activity per week, defined as anything that causes small increases in breathing or heart rate for a sustained amount of time (e.g., brisk walking, bicycling) 12. Engage in a mind-body practice less than 4 times a month Exclusion Criteria: 1. Another primary cancer diagnosis within past 5 years (not including non-melanoma skin cancers) 2. Any major thought disorder (e.g., schizophrenia, dementia) 3. Communication barriers (e.g., hard of hearing) 4. Poorly-controlled or uncontrolled diabetes in the opinion of the physician(s) 5. Extreme mobility issues (e.g., unable to get in and out of a chair unassisted)
What this study is about
In the sponsor’s own words, from the registry.
The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
Study sites(1)
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07179809. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me